Allergan. (AGN) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for Allergan. (AGN) over the last 10 years. The current PE ratio for Allergan. as of August 21, 2017 is 15.35.
|Medical||Medical - Generic Drugs||$74.881B||$14.571B|
|Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.|